Powered by Google Advanced Search
Benefits of Section Membership
Join ASHP
Join this Section
Issue Discussion Groups
Online Networking Directory
Activities and Reports
Executive Committee
Committees
Advisory Group
Elections
Summer Meeting
Midyear Clinical Meeting
Onoclogy Online Review Course
Psychiatric Online Review Course
Traineeships and Grants
Online CE Testing Center
 

Asthma Medications for Indigent Patients

This resource, originally compiled in 2000 by University of Florida pharmacy students Chris Fields and Andrea Ruygrok under the direction of Professor Leslie Hendeles, Pharm.D., was recently reorganized and updated by Virginia Commonwealth University pharmacy student Brandon Jennings. Now organized by drug name and manufacturer, the information is current as of July 21, 2003. (The American Society of Health-System Pharmacists is not responsible for the accuracy of the booklet’s contents).

Medication/Product Manufacture
Accolate AstraZeneca Pharmaceuticals
Advair Diskus GlaxoSmithKline Incorporated
Aerobid Forest Pharmaceuticals, Incorporated
Aerobid-M Forest Pharmaceuticals, Incorporated
Aerochamber with mask Forest Pharmaceuticals, Incorporated
Allegra Aventis Pharmaceuticals
Alupent Nebulizer Solution Boehringer Ingelheim Pharmaceuticals
Atrovent MDI Boehringer Ingelheim Pharmaceuticals
Azmacort Aventis Pharmaceuticals
Beconase AQ GlaxoSmithKline Incorporated
Claritin Schering Labs/Key Pharmaceuticals
Claritin Reditabs Schering Labs/Key Pharmaceuticals
Claritin-D Schering Labs/Key Pharmaceuticals
Combivent MDI Boehringer Ingelheim Pharmaceuticals
Deltasone Pfizer Incorporated
Flonase GlaxoSmithKline Incorporated
Flovent GlaxoSmithKline Incorporated
Flovent Rotadisk GlaxoSmithKline Incorporated
Foradil Aerolizer Schering Labs/Key Pharmaceuticals
Inspirease Schering Labs/Key Pharmaceuticals
Maxair Autohaler 3M Pharmaceuticals
Medrol Pfizer Incorporated
Nasacort Aventis Pharmaceuticals
Nasacort AQ Aventis Pharmaceuticals
Nasalcrom Pfizer Incorporated
Proventil HFA Schering Labs/Key Pharmaceuticals
Proventil MDI Schering Labs/Key Pharmaceuticals
Proventil Nebulizer Solution Schering Labs/Key Pharmaceuticals
Proventil Repetabs Schering Labs/Key Pharmaceuticals
Proventil Syrup Schering Labs/Key Pharmaceuticals
Pulmicort Respules AstraZeneca LP
Pulmicort Turbohaler AstraZeneca LP
Rhinocort AstraZeneca LP
Serevent MDI GlaxoSmithKline Incorporated
Servent Diskus GlaxoSmithKline Incorporated
Singulair Merck and Company
Theo-Dur Schering Labs/Key Pharmaceuticals
Vancenase Schering Labs/Key Pharmaceuticals
Vanceril Schering Labs/Key Pharmaceuticals
Vanceril DS Schering Labs/Key Pharmaceuticals
Ventolin GlaxoSmithKline Incorporated
Zyrtec Pfizer Incorporated

Program Details for Manufactures Providing Prescription Assistance Programs

3M Pharmaceuticals

Products:

  • Maxair™ Autohaler™
  • Theolair™

Program in place: Yes

Contact information:

3M Pharmaceuticals
3M Center Bldg. 275-6W-13
St. Paul, MN 55144
Phone: (800) 328-0255
Phone: (651) 733-1110 [alternate]
Fax: (651) 733-6068

Initiation

  • Anyone may call for the application form

Health Provider’s Role

  • Pharmacist
    • Can have application form faxed to pharmacy, filled out by patient and then have patient transport form to physician
  • Physician
    • Must complete a part of the application form

Patient’s Role

  • Complete a part of the application form

Eligibility

  • Must not have prescription insurance coverage
  • Must not qualify for state or federal assistance with his or her prescription medications
  • At or below 200% of U.S. Federal Poverty Level
  • Patient must be a legal resident of the U.S. with a Social Security Number

How Dispensed

  • Sent to physician
  • Quantities
    • Maxair™Autohaler™– 3 Autohalers™
    • TheolairT™– 300 Tablets (3 100 ct. bottles)

Repeat Process

  • Call must be placed to obtain another authorization form
  • Patients can all in their own re-orders

[Back to top]


AstraZeneca

Products:

  • Accolate®
  • Pulmicort Respules®
  • Rhinocort®
  • Pulmicort Turbuhaler®

Program in place: Yes

Contact Information

AstraZeneca Foundation Patient Assistant Program
P.O. Box 15197
Wilmington, DE 19850-5197
Phone: (800) 424-3727
Phone: (800) 698-0085 [alternate – pharmacy that dispenses medications for program]

Initiation

  • Anyone can call for the application form

Health Provider’s Role

  • Pharmacist
    • Can have application form faxed to pharmacy, filled out by patient and then have patient transport form to physician

Physician

  • Must complete part of application form and sign

Patient’s Role

  • Must provide detailed financial and insurance information
  • Must sign form
  • Provide $5 shipping and handling fee

Eligibility

  • Determined by
    • Monthly income
    • Assets
    • Lack of private insurance carrier
  • Must be a legal U.S. resident with a social security number

How dispensed

  • 90-day supply
  • Able to be sent to physician or patient via USPS

Quantities

  • Accolate® - 180 tablets (3 60 ct. bottles)
  • Pulmicort Respules® - 90 respules (3 30 respule boxes)
  • Pulmicort Turbuhaler® - 600 metered doses (3 200 metered devices)
  • Rhinocort Aqua® - 120-day supply (i spray per nostril qd)

Repeat process

  • Original application is valid for one year
  • Patient will automatically be notified before the end of one year to renew the process

[Back to top]


Aventis Pharmaceuticals

Products

  • Allegra®
  • Allegra®-D
  • Azmacort®
  • Nasacort®
  • Nasacort AQ®

Program in place: Yes

Contact information

Patient Assistance Program
P.O. Box 759
Somerville, NJ 08876
Phone: (800) 221-4025
Phone: (800) 207-8049 [alternate]

Initiation

  • Anyone can call to have application form mailed or faxed to physician

Health Provider’s Role

  • Pharmacist
    • Can call to have application form sent to physician
    • Can have application form faxed to pharmacy, filled out by patient and then have patient transport form to physician
  • Physician
    • Must complete application form
    • Send back to company

Patient’s Role

  • Attach copy of most recent Federal tax return
    • If patient does not file taxes, other proof of annual income must be supplied

Eligibility

  • Patient must be a legal U.S. resident
  • Cannot have or qualify for any prescription coverage under Medicare, Medicaid, Veteran’s Administration, or any state or local programs
  • Patient’s annual household income must be below the “Aventis Poverty Level” (chart available when application is requested)

How Dispensed

  • Maximum of a 90-day supply
  • Sent to physician’s office
  • Allow 4 weeks for delivery
  • Quantities
    • Allegra®– 100 ct. bottle
    • Allegra®-D – 100 ct. bottle
    • Azmacort® Inhalation Aerosol – 1 canister
    • Nasacort® Nasal Inhaler – 1 canister
    • Nasacort AQ® Nasal Spray – 1 canister

Repeat Process

  • Must send in application form with new prescription every 3 months

[Back to top]


Boehringer Ingelheim Pharmaceuticals

Products

  • Alupent® Nebulizer Solution
  • Atrovent® MDI
  • Combivent® MDI

Program in place: Yes

Contact information

Boehringer Ingelheim Cares Foundation, Inc.
c/o Express Scripts Specialty Distribution Services, Inc.
P.O. Box 66555
St. Louis, MO 63166-6773
Phone: (800) 556-8317
Phone: (203) 798-9988 [alternate]

Initiation

  • Anyone can call for the application form

Health Provider’s Role

  • Pharmacist
    • Can have application form faxed to pharmacy, filled out by patient and then have patient transport form to physician
  • Physician
    • Complete part of the application form
    • Provide a prescription
    • Submit to company

Patient’s Role

  • Must provide income and insurance information
  • Company prefers tax returns/W2 forms for income documentation
  • Visa if the patient is a non-U.S. citizen

How Dispensed

  • Maximum of a 90-day supply
  • Sent to physician

Repeat Process

  • Must submit copy of original application form with new prescription every 3 months
    • Original application form is valid for 1 year
  • After 1 year
    • Process must be started over

[Back to top]


Forest Pharmaceuticals, Incorporated

Products

  • Aerobid® Inhaler
  • Aerobid® M Inhaler
  • Aerochamber®
  • Aerochamber® Mask
  • TheochronTM

Program in place: Yes

Contact Information

Patient Assistance Program
13600 Shoreline Drive
St. Louis, MO 63045
Phone: (800) 851-0758
Phone: (314) 493-7000 [alternate]
Fax: (314) 493-7452

Initiation

  • Anyone may call for the application form

Health Provider’s Role

  • Pharmacist
    • Can have application form faxed to pharmacy, filled out by patient and then have patient transport form to physician
  • Physician
    • Must complete form
    • Attach prescription
    • Must mail application to company
      • No faxes, e-mails or photocopies will be accepted

Patient’s Role

  • Must provided detailed financial and insurance information for the household
  • Must sign form

How dispensed

  • 90-day supply of drug or device
  • Sent to licensed practitioner
    • Allow 6 weeks for delivery
  • Quantities
    • Aerobid® Inhaler – 7 g canister
    • Aerobid® M Inhaler – 7 g canister
    • Aerochamber®– N/A
    • Aerochamber® Mask – Sm, Reg, Lg
    • TheochronTM – 100 ct. bottle

Repeat Process

  • Application form with new prescription must be mailed to the company every 90 days

[Back to top]


GlaxoSmithKline, Incorporated

Products

Advair™ Diskus®
Beconase AQ®
Flonase®
Flovent®
FloventÒ Rotadisk®
Serevent® MDI
Serevent® Diskus®
Ventolin®
Ventolin® HFA

Program in place: Yes

Contact information

Bridges to Access
P.O. Box 29038
Phoenix, AZ 85038-9038
Phone: (866) 728-4368
Web: bridgestoaccess.gsk.com

Initiation

  • Physician or patient advocate* can obtain the application form at www.bridgestoaccess.com
  • After application form is completed, physician or patient advocate must call the company to
    • Give enrollment information
    • Wait for approval

Health Provider’s Role

  • Pharmacist/Physician/Patient Advocate
    • Able to help fill out the application form
    • Able to obtain conformation over the phone
    • Must mail to GlaxoSmithKline within 20 days of approval
    • Notify GSK if patient is no longer on the same medication therapy
  • Patient’s Role
    • Must provide insurance and proof of income

Eligibility

  • Must be a legal U.S. resident
  • Cannot qualify for prescription medication coverage with any public or private insurance/assistance carrier
  • Income cannot be greater than
    • $25 000 if a single member household, or
    • 250 % of poverty level if a multi-member household

How Dispensed

  • Immediate 60-day supply coupon given to patient after approval process is complete
    • Coupon entitles patient to receive medication for $5-co-pay per fill
    • Patient gives coupon to pharmacist
  • After enrollment form is processed, patient can be approved for two additional 90-day supplies of the medication by mail
    • Approximately two weeks before the first 90 days have surpassed, the patient must call (866) 728-4368 to request second 90-day supply be sent
  • Patient is eligible to participate for six months (can be extended to 12 months if needed, as approved by the patient advocate)
    • Advocate will be notified approximately 30 days before termination to request re-authorization
    • Advocate must notify GSK at (866) 728-4368 if patient is no longer on the same medication therapy
      * patient advocate must be someone involved in the direct care of the patient; cannot be a family member or friend of the patient

[Back to top]


Merck & Company, Incorporated

Products

  • Singulair®

Program in place: Yes

Contact information

Merck Patient Assistance Program
P.O. Box 690
Horsham, PA 19044-9979
Phone: (800) 994-2111
Phone: (800) 727-5400 [alternate]

Initiation

  • Applications are mailed out in bulk (qnty. 25)
  • Preferable for pharmacist or physician to call for applications and display in pharmacy or office

Health Provider’s Role

  • Pharmacist
    • Can have application form faxed to pharmacy, filled out by patient and then have patient transport form to physician
  • Physician
    • Complete part of the application form
    • Provide a prescription
    • Submit to company (unstapled)

Patient’s Role

  • Provide financial information
  • Sign the form

Eligibility

  • Must live in the United States and have a prescription from a doctor licensed in the United States for a Merck medication
  • Cannot have insurance or other coverage for prescription medications
    • Must exhaust all other options
      • HMOs, Medicaid, Medicare, state pharmacy assistance programs, Veteran’s assistance, etc.
  • Income cannot be greater than
    • $18 000 if a single member household, or
    • $24 000 if a two member household, or
    • $35 000 if a four member household
      ** if special circumstance apply, the physician may request for an exception to be made**

How Dispensed

  • 90-day supply with a maximum of 3 refills
  • Sent to patient’s home unless otherwise indicated by the physician
  • Approval is granted for a maximum of 1 year

[Back to top]


Pfizer Incorporated

Products

  • Zyrtec®

Program in place: Yes

Contact information

Pfizer Connection to Care Program
P.O. Box 66585
St. Louis, MO 63166-6585
Phone: (800) 707-8990
Phone: (800) 438-1985 [alternate]

Initiation

  • Anyone can call to obtain the guidelines for the program

Health Provider’s Role

  • Pharmacist
    • Can have application form faxed to pharmacy, filled out by patient and then have patient transport form to physician
  • Physician
    • Will need to send a letter on official letterhead stationary
      • Must include specific information
      • By mail only
    • Will need to attach prescription

Patient’s Role

  • Must provide insurance information

Eligibility

  • Must be a legal U.S. resident
  • Cannot qualify for prescription medication coverage with any public or private insurance/assistance carrier
  • Income cannot be greater than
    • $16 000 if a single member household, or
    • $25 000 if a family household

How Dispensed

  • 90-day supply
  • Sent to physician

Repeat Process

  • Re-apply every three months
  • Tax return and income documentation only needs to be supplied once every year

[Back to top]


Schering Labs/Key Pharmaceuticals

Products

  • Foradil® Aerolizer™ (in US, non-US made by Novartis)
  • Proventil® MDI
  • Proventil® HFA
  • Proventil® Nebulizer Solution

Program in place: Yes

Contact information

Schering Lab/Key Pharmaceuticals Patient Assistance Program
P.O. Box 52122
Phoenix, AZ 85072
Phone: (800) 656-9485
Phone: (800) 222-7579 [alternate]

Initiation

  • Physician or patient advocate may request the application form be sent
  • Application form must be original

Health Provider’s Role

  • Pharmacist
    • Can have application form faxed to pharmacy, filled out by patient and then have patient transport form to physician
  • Physician
  • Must complete and sign the application form
    • Must provide written prescription

Patient’s Role

  • Must complete the application form
  • Must provide proof of monthly income

Eligibility

  • If the patient has no income
    • Physician or social worker must indicate this on company letterhead
  • Cannot qualify for prescription medication coverage with any public or private insurance/assistance carrier

How Dispensed

  • 90-day supply
  • Sent to physician’s office

Repeat Process

  • Reorder form will be included with the approval letter

[Back to top]


No program in place

  1. Abbott Laboratories - Zyflo®
  2. Dey Laboratories – Albuterol MDI, Albuterol Nebulizer Solution, Easivent® Spacer
  3. Muro Pharmaceuticals, Inc. - Prelone®, Volmax® (out of business)
  4. Mylan Laboratories, Incorporated – Albuterol
  5. Purdue Frederick - Uniphyl® (samples program)
  6. Roxane Laboratories – Prednisone
  7. Sepracor - Xopenex®
  8. Wyeth Laboratories – Albuterol Tablets

[Back to top]